FilingSEC EDGARS-8
Moleculin Biotech Files S-8 to Register Shares for Equity Plan
· SEC accepted
StageOther
Filing content
Moleculin Biotech filed an S-8 registration statement for an additional 3,861,894 shares of common stock to be issued under its 2024 Stock Plan.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…